nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefixime—SLC15A2—Chlorpropamide—type 2 diabetes mellitus	0.11	0.136	CbGbCtD
Cefixime—SLC15A2—Tolbutamide—type 2 diabetes mellitus	0.098	0.121	CbGbCtD
Cefixime—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.0947	0.117	CbGbCtD
Cefixime—SLC15A2—Ramipril—type 2 diabetes mellitus	0.0874	0.108	CbGbCtD
Cefixime—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.0844	0.104	CbGbCtD
Cefixime—SLC15A2—Nateglinide—type 2 diabetes mellitus	0.0834	0.103	CbGbCtD
Cefixime—SLC15A1—Ramipril—type 2 diabetes mellitus	0.0753	0.0929	CbGbCtD
Cefixime—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.0718	0.0886	CbGbCtD
Cefixime—SLC15A2—Glyburide—type 2 diabetes mellitus	0.0563	0.0695	CbGbCtD
Cefixime—SLC15A1—Glyburide—type 2 diabetes mellitus	0.0485	0.0599	CbGbCtD
Cefixime—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000347	0.00186	CcSEcCtD
Cefixime—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000346	0.00186	CcSEcCtD
Cefixime—Haemoglobin—Orlistat—type 2 diabetes mellitus	0.000346	0.00186	CcSEcCtD
Cefixime—Haemorrhage—Orlistat—type 2 diabetes mellitus	0.000344	0.00185	CcSEcCtD
Cefixime—Hepatitis—Orlistat—type 2 diabetes mellitus	0.000344	0.00185	CcSEcCtD
Cefixime—Rash—Nateglinide—type 2 diabetes mellitus	0.000343	0.00184	CcSEcCtD
Cefixime—Dyspepsia—Glipizide—type 2 diabetes mellitus	0.000343	0.00184	CcSEcCtD
Cefixime—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000343	0.00184	CcSEcCtD
Cefixime—Angioedema—Glyburide—type 2 diabetes mellitus	0.000336	0.0018	CcSEcCtD
Cefixime—Nausea—Acarbose—type 2 diabetes mellitus	0.000335	0.0018	CcSEcCtD
Cefixime—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000333	0.00179	CcSEcCtD
Cefixime—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000329	0.00177	CcSEcCtD
Cefixime—Renal failure—Irbesartan—type 2 diabetes mellitus	0.000328	0.00176	CcSEcCtD
Cefixime—Flatulence—Gliclazide—type 2 diabetes mellitus	0.000325	0.00175	CcSEcCtD
Cefixime—Jaundice—Irbesartan—type 2 diabetes mellitus	0.000325	0.00175	CcSEcCtD
Cefixime—Urinary tract infection—Irbesartan—type 2 diabetes mellitus	0.000324	0.00174	CcSEcCtD
Cefixime—Nausea—Nateglinide—type 2 diabetes mellitus	0.000323	0.00174	CcSEcCtD
Cefixime—Shock—Bromocriptine—type 2 diabetes mellitus	0.000323	0.00173	CcSEcCtD
Cefixime—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000322	0.00173	CcSEcCtD
Cefixime—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.00032	0.00172	CcSEcCtD
Cefixime—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000319	0.00171	CcSEcCtD
Cefixime—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000319	0.00171	CcSEcCtD
Cefixime—Convulsion—Glyburide—type 2 diabetes mellitus	0.000318	0.00171	CcSEcCtD
Cefixime—Hepatitis—Metformin—type 2 diabetes mellitus	0.000317	0.0017	CcSEcCtD
Cefixime—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000315	0.00169	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Ramipril—type 2 diabetes mellitus	0.000314	0.00169	CcSEcCtD
Cefixime—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000311	0.00167	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.000311	0.00167	CcSEcCtD
Cefixime—Urticaria—Glipizide—type 2 diabetes mellitus	0.000309	0.00166	CcSEcCtD
Cefixime—Renal failure—Losartan—type 2 diabetes mellitus	0.000308	0.00166	CcSEcCtD
Cefixime—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000308	0.00166	CcSEcCtD
Cefixime—Jaundice—Losartan—type 2 diabetes mellitus	0.000306	0.00164	CcSEcCtD
Cefixime—Urinary tract infection—Losartan—type 2 diabetes mellitus	0.000305	0.00164	CcSEcCtD
Cefixime—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000304	0.00164	CcSEcCtD
Cefixime—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000301	0.00162	CcSEcCtD
Cefixime—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000299	0.00161	CcSEcCtD
Cefixime—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.000299	0.00161	CcSEcCtD
Cefixime—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.000299	0.00161	CcSEcCtD
Cefixime—Flatulence—Valsartan—type 2 diabetes mellitus	0.000299	0.00161	CcSEcCtD
Cefixime—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000297	0.0016	CcSEcCtD
Cefixime—Rash—Repaglinide—type 2 diabetes mellitus	0.000297	0.0016	CcSEcCtD
Cefixime—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000297	0.00159	CcSEcCtD
Cefixime—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000296	0.00159	CcSEcCtD
Cefixime—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000296	0.00159	CcSEcCtD
Cefixime—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000295	0.00159	CcSEcCtD
Cefixime—Flatulence—Orlistat—type 2 diabetes mellitus	0.000295	0.00159	CcSEcCtD
Cefixime—Headache—Repaglinide—type 2 diabetes mellitus	0.000295	0.00159	CcSEcCtD
Cefixime—Shock—Glyburide—type 2 diabetes mellitus	0.000295	0.00159	CcSEcCtD
Cefixime—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000294	0.00158	CcSEcCtD
Cefixime—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000294	0.00158	CcSEcCtD
Cefixime—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000293	0.00157	CcSEcCtD
Cefixime—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000289	0.00155	CcSEcCtD
Cefixime—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000289	0.00155	CcSEcCtD
Cefixime—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000288	0.00155	CcSEcCtD
Cefixime—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000287	0.00154	CcSEcCtD
Cefixime—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000287	0.00154	CcSEcCtD
Cefixime—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000286	0.00154	CcSEcCtD
Cefixime—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.000286	0.00154	CcSEcCtD
Cefixime—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000286	0.00154	CcSEcCtD
Cefixime—Neutropenia—Ramipril—type 2 diabetes mellitus	0.000282	0.00152	CcSEcCtD
Cefixime—Hepatitis—Losartan—type 2 diabetes mellitus	0.000282	0.00151	CcSEcCtD
Cefixime—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000281	0.00151	CcSEcCtD
Cefixime—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00028	0.00151	CcSEcCtD
Cefixime—Nausea—Repaglinide—type 2 diabetes mellitus	0.00028	0.0015	CcSEcCtD
Cefixime—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000279	0.0015	CcSEcCtD
Cefixime—Angioedema—Valsartan—type 2 diabetes mellitus	0.000277	0.00149	CcSEcCtD
Cefixime—Pruritus—Glipizide—type 2 diabetes mellitus	0.000276	0.00148	CcSEcCtD
Cefixime—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000275	0.00148	CcSEcCtD
Cefixime—Angioedema—Orlistat—type 2 diabetes mellitus	0.000274	0.00147	CcSEcCtD
Cefixime—Flatulence—Metformin—type 2 diabetes mellitus	0.000272	0.00146	CcSEcCtD
Cefixime—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000268	0.00144	CcSEcCtD
Cefixime—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000268	0.00144	CcSEcCtD
Cefixime—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000267	0.00144	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000267	0.00143	CcSEcCtD
Cefixime—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000267	0.00143	CcSEcCtD
Cefixime—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000266	0.00143	CcSEcCtD
Cefixime—Renal failure—Ramipril—type 2 diabetes mellitus	0.000264	0.00142	CcSEcCtD
Cefixime—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000264	0.00142	CcSEcCtD
Cefixime—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000264	0.00142	CcSEcCtD
Cefixime—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000264	0.00142	CcSEcCtD
Cefixime—Jaundice—Ramipril—type 2 diabetes mellitus	0.000262	0.00141	CcSEcCtD
Cefixime—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000261	0.00141	CcSEcCtD
Cefixime—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000261	0.0014	CcSEcCtD
Cefixime—Convulsion—Orlistat—type 2 diabetes mellitus	0.000259	0.00139	CcSEcCtD
Cefixime—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000259	0.00139	CcSEcCtD
Cefixime—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000259	0.00139	CcSEcCtD
Cefixime—Dizziness—Glipizide—type 2 diabetes mellitus	0.000258	0.00138	CcSEcCtD
Cefixime—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000257	0.00138	CcSEcCtD
Cefixime—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000257	0.00138	CcSEcCtD
Cefixime—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000255	0.00137	CcSEcCtD
Cefixime—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000251	0.00135	CcSEcCtD
Cefixime—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000249	0.00134	CcSEcCtD
Cefixime—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000248	0.00133	CcSEcCtD
Cefixime—Vomiting—Glipizide—type 2 diabetes mellitus	0.000248	0.00133	CcSEcCtD
Cefixime—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000247	0.00133	CcSEcCtD
Cefixime—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000247	0.00133	CcSEcCtD
Cefixime—Rash—Glipizide—type 2 diabetes mellitus	0.000246	0.00132	CcSEcCtD
Cefixime—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000245	0.00132	CcSEcCtD
Cefixime—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000245	0.00132	CcSEcCtD
Cefixime—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000244	0.00131	CcSEcCtD
Cefixime—Headache—Glipizide—type 2 diabetes mellitus	0.000244	0.00131	CcSEcCtD
Cefixime—Shock—Valsartan—type 2 diabetes mellitus	0.000243	0.00131	CcSEcCtD
Cefixime—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000242	0.0013	CcSEcCtD
Cefixime—Flatulence—Losartan—type 2 diabetes mellitus	0.000242	0.0013	CcSEcCtD
Cefixime—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000241	0.0013	CcSEcCtD
Cefixime—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00024	0.00129	CcSEcCtD
Cefixime—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00024	0.00129	CcSEcCtD
Cefixime—Urticaria—Glyburide—type 2 diabetes mellitus	0.000238	0.00128	CcSEcCtD
Cefixime—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000238	0.00128	CcSEcCtD
Cefixime—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000237	0.00127	CcSEcCtD
Cefixime—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000237	0.00127	CcSEcCtD
Cefixime—Headache—Pioglitazone—type 2 diabetes mellitus	0.000234	0.00126	CcSEcCtD
Cefixime—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000233	0.00125	CcSEcCtD
Cefixime—Nausea—Glipizide—type 2 diabetes mellitus	0.000231	0.00124	CcSEcCtD
Cefixime—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000231	0.00124	CcSEcCtD
Cefixime—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00023	0.00124	CcSEcCtD
Cefixime—Rash—Glimepiride—type 2 diabetes mellitus	0.000229	0.00123	CcSEcCtD
Cefixime—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000229	0.00123	CcSEcCtD
Cefixime—Rash—Sitagliptin—type 2 diabetes mellitus	0.000229	0.00123	CcSEcCtD
Cefixime—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000228	0.00123	CcSEcCtD
Cefixime—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000228	0.00123	CcSEcCtD
Cefixime—Headache—Glimepiride—type 2 diabetes mellitus	0.000228	0.00122	CcSEcCtD
Cefixime—Headache—Sitagliptin—type 2 diabetes mellitus	0.000227	0.00122	CcSEcCtD
Cefixime—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000224	0.00121	CcSEcCtD
Cefixime—Angioedema—Losartan—type 2 diabetes mellitus	0.000224	0.0012	CcSEcCtD
Cefixime—Shock—Metformin—type 2 diabetes mellitus	0.000222	0.00119	CcSEcCtD
Cefixime—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000221	0.00119	CcSEcCtD
Cefixime—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000221	0.00119	CcSEcCtD
Cefixime—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00022	0.00118	CcSEcCtD
Cefixime—Leukopenia—Losartan—type 2 diabetes mellitus	0.000219	0.00118	CcSEcCtD
Cefixime—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000218	0.00117	CcSEcCtD
Cefixime—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000217	0.00117	CcSEcCtD
Cefixime—Nausea—Glimepiride—type 2 diabetes mellitus	0.000216	0.00116	CcSEcCtD
Cefixime—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000215	0.00116	CcSEcCtD
Cefixime—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000215	0.00116	CcSEcCtD
Cefixime—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000214	0.00115	CcSEcCtD
Cefixime—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000213	0.00114	CcSEcCtD
Cefixime—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000213	0.00114	CcSEcCtD
Cefixime—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000213	0.00114	CcSEcCtD
Cefixime—Pruritus—Glyburide—type 2 diabetes mellitus	0.000212	0.00114	CcSEcCtD
Cefixime—Shock—Irbesartan—type 2 diabetes mellitus	0.000209	0.00112	CcSEcCtD
Cefixime—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000209	0.00112	CcSEcCtD
Cefixime—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000208	0.00112	CcSEcCtD
Cefixime—Rash—Bromocriptine—type 2 diabetes mellitus	0.000207	0.00111	CcSEcCtD
Cefixime—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000207	0.00111	CcSEcCtD
Cefixime—Headache—Bromocriptine—type 2 diabetes mellitus	0.000205	0.0011	CcSEcCtD
Cefixime—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000205	0.0011	CcSEcCtD
Cefixime—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000202	0.00109	CcSEcCtD
Cefixime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.000201	0.0497	CbGpPWpGaD
Cefixime—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.0002	0.00108	CcSEcCtD
Cefixime—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.0002	0.00107	CcSEcCtD
Cefixime—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000198	0.00107	CcSEcCtD
Cefixime—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000198	0.00107	CcSEcCtD
Cefixime—Shock—Losartan—type 2 diabetes mellitus	0.000197	0.00106	CcSEcCtD
Cefixime—Urticaria—Valsartan—type 2 diabetes mellitus	0.000196	0.00106	CcSEcCtD
Cefixime—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000196	0.00105	CcSEcCtD
Cefixime—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000196	0.00105	CcSEcCtD
Cefixime—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000195	0.00105	CcSEcCtD
Cefixime—Urticaria—Orlistat—type 2 diabetes mellitus	0.000194	0.00104	CcSEcCtD
Cefixime—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000193	0.00104	CcSEcCtD
Cefixime—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000193	0.00104	CcSEcCtD
Cefixime—Angioedema—Ramipril—type 2 diabetes mellitus	0.000192	0.00103	CcSEcCtD
Cefixime—Vomiting—Glyburide—type 2 diabetes mellitus	0.000191	0.00102	CcSEcCtD
Cefixime—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00019	0.00102	CcSEcCtD
Cefixime—Rash—Glyburide—type 2 diabetes mellitus	0.000189	0.00102	CcSEcCtD
Cefixime—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000189	0.00102	CcSEcCtD
Cefixime—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000188	0.00101	CcSEcCtD
Cefixime—Headache—Glyburide—type 2 diabetes mellitus	0.000188	0.00101	CcSEcCtD
Cefixime—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000187	0.00101	CcSEcCtD
Cefixime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.000186	0.0461	CbGpPWpGaD
Cefixime—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000184	0.00099	CcSEcCtD
Cefixime—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000184	0.00099	CcSEcCtD
Cefixime—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000182	0.00098	CcSEcCtD
Cefixime—Convulsion—Ramipril—type 2 diabetes mellitus	0.000182	0.000979	CcSEcCtD
Cefixime—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00018	0.000968	CcSEcCtD
Cefixime—Urticaria—Metformin—type 2 diabetes mellitus	0.000179	0.000962	CcSEcCtD
Cefixime—Nausea—Glyburide—type 2 diabetes mellitus	0.000178	0.000957	CcSEcCtD
Cefixime—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000178	0.000957	CcSEcCtD
Cefixime—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000178	0.000957	CcSEcCtD
Cefixime—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000176	0.000947	CcSEcCtD
Cefixime—Pruritus—Valsartan—type 2 diabetes mellitus	0.000175	0.000941	CcSEcCtD
Cefixime—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000174	0.000934	CcSEcCtD
Cefixime—Pruritus—Orlistat—type 2 diabetes mellitus	0.000173	0.000929	CcSEcCtD
Cefixime—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000172	0.000922	CcSEcCtD
Cefixime—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000171	0.00092	CcSEcCtD
Cefixime—Rash—Gliclazide—type 2 diabetes mellitus	0.00017	0.000912	CcSEcCtD
Cefixime—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00017	0.000912	CcSEcCtD
Cefixime—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000169	0.00091	CcSEcCtD
Cefixime—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000169	0.000908	CcSEcCtD
Cefixime—Shock—Ramipril—type 2 diabetes mellitus	0.000169	0.000907	CcSEcCtD
Cefixime—Headache—Gliclazide—type 2 diabetes mellitus	0.000169	0.000907	CcSEcCtD
Cefixime—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000168	0.000903	CcSEcCtD
Cefixime—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000168	0.000903	CcSEcCtD
Cefixime—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000168	0.000903	CcSEcCtD
Cefixime—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000167	0.000899	CcSEcCtD
Cefixime—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000164	0.000879	CcSEcCtD
Cefixime—Dizziness—Valsartan—type 2 diabetes mellitus	0.000164	0.000879	CcSEcCtD
Cefixime—Dizziness—Orlistat—type 2 diabetes mellitus	0.000162	0.000869	CcSEcCtD
Cefixime—Nausea—Gliclazide—type 2 diabetes mellitus	0.00016	0.00086	CcSEcCtD
Cefixime—Pruritus—Metformin—type 2 diabetes mellitus	0.000159	0.000857	CcSEcCtD
Cefixime—Urticaria—Losartan—type 2 diabetes mellitus	0.000159	0.000854	CcSEcCtD
Cefixime—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000158	0.00085	CcSEcCtD
Cefixime—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000158	0.00085	CcSEcCtD
Cefixime—Vomiting—Valsartan—type 2 diabetes mellitus	0.000157	0.000845	CcSEcCtD
Cefixime—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000157	0.000842	CcSEcCtD
Cefixime—Rash—Valsartan—type 2 diabetes mellitus	0.000156	0.000838	CcSEcCtD
Cefixime—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000156	0.000838	CcSEcCtD
Cefixime—Vomiting—Orlistat—type 2 diabetes mellitus	0.000155	0.000835	CcSEcCtD
Cefixime—Headache—Valsartan—type 2 diabetes mellitus	0.000155	0.000833	CcSEcCtD
Cefixime—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000154	0.000828	CcSEcCtD
Cefixime—Rash—Orlistat—type 2 diabetes mellitus	0.000154	0.000828	CcSEcCtD
Cefixime—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000154	0.000828	CcSEcCtD
Cefixime—Headache—Orlistat—type 2 diabetes mellitus	0.000153	0.000823	CcSEcCtD
Cefixime—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000151	0.000812	CcSEcCtD
Cefixime—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00015	0.000808	CcSEcCtD
Cefixime—Dizziness—Metformin—type 2 diabetes mellitus	0.000149	0.000801	CcSEcCtD
Cefixime—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000147	0.000792	CcSEcCtD
Cefixime—Nausea—Valsartan—type 2 diabetes mellitus	0.000147	0.00079	CcSEcCtD
Cefixime—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000145	0.000782	CcSEcCtD
Cefixime—Nausea—Orlistat—type 2 diabetes mellitus	0.000145	0.00078	CcSEcCtD
Cefixime—Vomiting—Metformin—type 2 diabetes mellitus	0.000143	0.00077	CcSEcCtD
Cefixime—Rash—Metformin—type 2 diabetes mellitus	0.000142	0.000763	CcSEcCtD
Cefixime—Dermatitis—Metformin—type 2 diabetes mellitus	0.000142	0.000763	CcSEcCtD
Cefixime—Pruritus—Losartan—type 2 diabetes mellitus	0.000142	0.000761	CcSEcCtD
Cefixime—Headache—Metformin—type 2 diabetes mellitus	0.000141	0.000758	CcSEcCtD
Cefixime—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000141	0.000756	CcSEcCtD
Cefixime—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.00014	0.000754	CcSEcCtD
Cefixime—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000137	0.000736	CcSEcCtD
Cefixime—Urticaria—Ramipril—type 2 diabetes mellitus	0.000136	0.000732	CcSEcCtD
Cefixime—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000136	0.000729	CcSEcCtD
Cefixime—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000136	0.000729	CcSEcCtD
Cefixime—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000135	0.000726	CcSEcCtD
Cefixime—Rash—Irbesartan—type 2 diabetes mellitus	0.000134	0.00072	CcSEcCtD
Cefixime—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000134	0.00072	CcSEcCtD
Cefixime—Nausea—Metformin—type 2 diabetes mellitus	0.000134	0.000719	CcSEcCtD
Cefixime—Headache—Irbesartan—type 2 diabetes mellitus	0.000133	0.000716	CcSEcCtD
Cefixime—Dizziness—Losartan—type 2 diabetes mellitus	0.000132	0.000711	CcSEcCtD
Cefixime—Vomiting—Losartan—type 2 diabetes mellitus	0.000127	0.000684	CcSEcCtD
Cefixime—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000126	0.000679	CcSEcCtD
Cefixime—Nausea—Irbesartan—type 2 diabetes mellitus	0.000126	0.000679	CcSEcCtD
Cefixime—Rash—Losartan—type 2 diabetes mellitus	0.000126	0.000678	CcSEcCtD
Cefixime—Dermatitis—Losartan—type 2 diabetes mellitus	0.000126	0.000677	CcSEcCtD
Cefixime—Headache—Losartan—type 2 diabetes mellitus	0.000125	0.000674	CcSEcCtD
Cefixime—Pruritus—Ramipril—type 2 diabetes mellitus	0.000121	0.000652	CcSEcCtD
Cefixime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A4—type 2 diabetes mellitus	0.00012	0.0298	CbGpPWpGaD
Cefixime—Nausea—Losartan—type 2 diabetes mellitus	0.000119	0.000639	CcSEcCtD
Cefixime—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000117	0.000631	CcSEcCtD
Cefixime—Dizziness—Ramipril—type 2 diabetes mellitus	0.000113	0.00061	CcSEcCtD
Cefixime—Vomiting—Ramipril—type 2 diabetes mellitus	0.000109	0.000586	CcSEcCtD
Cefixime—Rash—Ramipril—type 2 diabetes mellitus	0.000108	0.000581	CcSEcCtD
Cefixime—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000108	0.000581	CcSEcCtD
Cefixime—Headache—Ramipril—type 2 diabetes mellitus	0.000107	0.000578	CcSEcCtD
Cefixime—Nausea—Ramipril—type 2 diabetes mellitus	0.000102	0.000548	CcSEcCtD
Cefixime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—type 2 diabetes mellitus	9.47e-05	0.0234	CbGpPWpGaD
Cefixime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—type 2 diabetes mellitus	9.11e-05	0.0226	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	8.97e-05	0.0222	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	8.33e-05	0.0206	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	8.19e-05	0.0203	CbGpPWpGaD
Cefixime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	6.46e-05	0.016	CbGpPWpGaD
Cefixime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	6.23e-05	0.0154	CbGpPWpGaD
Cefixime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	6e-05	0.0148	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	5.99e-05	0.0148	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	5.78e-05	0.0143	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	5.56e-05	0.0138	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	5.46e-05	0.0135	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	5.37e-05	0.0133	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	5.28e-05	0.0131	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	4.71e-05	0.0117	CbGpPWpGaD
Cefixime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	4.62e-05	0.0114	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	4.56e-05	0.0113	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	4.54e-05	0.0112	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	4.37e-05	0.0108	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	4.3e-05	0.0106	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	4.23e-05	0.0105	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	4.21e-05	0.0104	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	4.16e-05	0.0103	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	4.14e-05	0.0102	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	3.86e-05	0.00955	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	3.73e-05	0.00922	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	3.58e-05	0.00886	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	3.52e-05	0.00871	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	3.46e-05	0.00856	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	3.4e-05	0.00842	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	3.1e-05	0.00767	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	3.04e-05	0.00753	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	2.96e-05	0.00733	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	2.94e-05	0.00727	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	2.94e-05	0.00727	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	2.89e-05	0.00715	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	2.88e-05	0.00712	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	2.83e-05	0.007	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	2.82e-05	0.00699	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	2.78e-05	0.00687	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	2.75e-05	0.0068	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	2.73e-05	0.00675	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	2.73e-05	0.00675	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	2.7e-05	0.00669	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	2.69e-05	0.00665	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	2.68e-05	0.00664	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	2.68e-05	0.00664	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	2.68e-05	0.00664	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	2.64e-05	0.00653	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	2.49e-05	0.00617	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	2.45e-05	0.00607	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	2.4e-05	0.00594	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	2.4e-05	0.00593	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	2.4e-05	0.00593	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	2.31e-05	0.00571	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	2.31e-05	0.00571	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	2.3e-05	0.0057	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	2.26e-05	0.00561	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	2.23e-05	0.00551	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	2.22e-05	0.0055	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	2.22e-05	0.0055	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	2.19e-05	0.00542	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	2.19e-05	0.00541	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	2.19e-05	0.00541	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	2.14e-05	0.0053	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	2.14e-05	0.0053	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	2.14e-05	0.00529	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	2.1e-05	0.00521	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	2.1e-05	0.00521	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	2.1e-05	0.0052	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	2.1e-05	0.0052	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	2.09e-05	0.00518	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	2.07e-05	0.00512	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	1.96e-05	0.00485	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	1.96e-05	0.00484	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	1.94e-05	0.00481	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	1.91e-05	0.00473	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	1.89e-05	0.00469	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	1.82e-05	0.0045	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	1.82e-05	0.0045	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	1.82e-05	0.00449	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	1.79e-05	0.00443	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	1.79e-05	0.00442	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	1.76e-05	0.00435	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	1.73e-05	0.00428	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	1.68e-05	0.00417	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	1.66e-05	0.0041	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.58e-05	0.0039	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.5e-05	0.00372	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.5e-05	0.00372	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.47e-05	0.00363	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.46e-05	0.00362	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.46e-05	0.00361	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.45e-05	0.00359	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.44e-05	0.00356	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.4e-05	0.00345	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.4e-05	0.00345	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.37e-05	0.0034	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.37e-05	0.0034	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.36e-05	0.00337	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.35e-05	0.00335	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.35e-05	0.00333	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.34e-05	0.00332	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.33e-05	0.0033	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.32e-05	0.00328	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.28e-05	0.00317	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.22e-05	0.00302	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.19e-05	0.00294	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.19e-05	0.00293	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.17e-05	0.00289	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.17e-05	0.00289	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.13e-05	0.0028	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.11e-05	0.00276	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.1e-05	0.00272	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.09e-05	0.00269	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.08e-05	0.00268	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.07e-05	0.00264	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.01e-05	0.0025	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1e-05	0.00248	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	9.95e-06	0.00246	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	9.61e-06	0.00238	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	9.36e-06	0.00232	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	9.31e-06	0.00231	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	9.23e-06	0.00228	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	9.2e-06	0.00228	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	9.16e-06	0.00227	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	9.08e-06	0.00225	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.99e-06	0.00222	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	8.92e-06	0.00221	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	8.77e-06	0.00217	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.34e-06	0.00206	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.2e-06	0.00203	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	8.11e-06	0.00201	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7.61e-06	0.00188	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.52e-06	0.00186	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.4e-06	0.00183	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7.06e-06	0.00175	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	6.94e-06	0.00172	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.03e-06	0.00149	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.59e-06	0.00138	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.5e-06	0.00136	CbGpPWpGaD
